Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Paul Rothman, Kevin Watson, David Flannery

Premium

Cancer Genetics has appointed Paul Rothman, dean of the medical faculty and CEO of Johns Hopkins Medicine, to serve on its board of directors.

Rothman oversees the Johns Hopkins Health System and the School of Medicine, and before that he was dean of the University of Iowa's Carver College of Medicine. He also formerly was head of internal medicine at UI and vice chairman for research and founding director of the pulmonary, allergy, and critical care division at Columbia University College of Physicians.


Rosetta Genomics has appointed Kevin Watson to be director of reimbursement and managed care.

Watson joins Rosetta Genomics from BioTheranostics, where he was director of reimbursement. He formerly was president of GlobalPayer, a payer relations and reimbursement firm, and he spent six years in regional marketing and payer relations at Becton Dickinson Diagnostics – TriPath Imaging.


David Flannery, a pediatric geneticist, is the new medical director of the American College of Medical Genetics and Genomics.

Flannery is a founding fellow at ACMG, co-chair of its Economics of Genetic Services committee, as well as a member of its Professional Practice and Guidelines committee and CPT and Reimbursement subcommittee. He also represents ACMG on the American Medical Association's CPT advisory committee.

The Scan

Study Reveals Details of SARS-CoV-2 Spread Across Brazil

A genomic analysis in Nature Microbiology explores how SARS-CoV-2 spread into, across, and from Brazil.

New Study Highlights Utility of Mutation Testing in Anaplastic Thyroid Cancer

Genetic mutations in BRAF and RAS are associated with patient outcomes in anaplastic thyroid carcinoma, a new JCO Precision Oncology study reports.

Study Points to Increased Risk of Dangerous Blood Clots in COVID-19 Patients

An analysis in JAMA Internal Medicine finds that even mild COVID-19 increases risk of venous thromboembolism.

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.